Omeprazole Magnesium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 15 USDMF, 9 CEP/COS, 12 EU WC, 8 NDC API, 14 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

FINISHED DOSAGE FORMULATIONS

37 FDF Dossiers, 12 FDA Orange Book, 7 Europe, 13 Canada, 5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 10MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Evonik, 4 Rochem International Inc, 14 SPI Pharma, 2 Seqens, 14 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 7 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 25 BASF, 14 Corel Pharma Chem, 3 DFE Pharma, 3 Doshion Polyscience, 3 Finar, 13 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 24 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 14 Roquette, 13 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

68 Coating Systems & Additives, 56 Fillers, Diluents & Binders, 40 Controlled & Modified Release, 37 Thickeners and Stabilizers, 34 Direct Compression, 25 Solubilizers, 24 Taste Masking, 22 Lubricants & Glidants, 20 Disintegrants & Superdisintegrants, 19 Granulation, 18 Topical, 16 Chewable & Orodispersible Aids, 16 Parenteral, 15 Film Formers & Plasticizers, 15 Co-Processed Excipients, 9 Emulsifying Agents, 9 Empty Capsules, 8 Rheology Modifiers, 7 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 10 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 Finished Drug Prices

1 Finished Drug Prices

MARKET PLACE

2 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 US Patents, 2 US Exclusivities, 38 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 1 USP, 1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22056 / DOSAGE - FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
OMEPRAZOLE MAGNESIUM(UNII: 426QFE7XLK) (OMEPRAZOLE - UNII:KG60484QX9)	OMEPRAZOLE	10mg \| 2.5mg \| 40mg \| 20mg \| 10mg

Inactive Ingredients

Ingredient Name	AstraZeneca Pharmaceuticals LP
ALCOHOL(3K9958V90M)
ANHYDROUS CITRIC ACID(XF417D3PSL)
ANHYDROUS DEXTROSE(5SL0G7R0OK)
ANHYDROUS LACTOSE(3SY5LH9PMK)
BUTYL ALCOHOL(8PJ61P6TS3)
D&C RED NO. 28(767IP0Y5NH)
D&C RED NO. 7(ECW0LZ41X8)
D&C YELLOW NO. 10(35SW5USQ3G)
FD&C BLUE NO. 1(H3R47K3TBD)
FD&C BLUE NO. 2(L06K8R7DQK)
FD&C RED NO. 40(WZB9127XOA)
FERROSOFERRIC OXIDE(XM0M87F357)
GELATIN(2G86QN327L)
GLYCERYL MONOSTEARATE(230OU9XXE4)
HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P)
HYPROMELLOSES(3NXW29V3WO)
MAGNESIUM STEARATE(70097M6I30)
MANNITOL(3OWL53L36A)
METHACRYLIC ACID(1CS02G8656)
POLYSORBATE 80(6OZP39ZG8H)
SODIUM HYDROXIDE(55X04QC32I)
SODIUM LAURYL SULFATE(368GB5141J)
TALC(7SEV7J4R1U)
TITANIUM DIOXIDE(15FIX9V2JP)
TRIETHYL CITRATE(8Z96QXD6UM)
XANTHAN GUM(TTV12P4NEE)

Drug Product Composition: Omeprazole Magnesium